Top news of the week on Specialty Pharmacy Times.
Reimbursement
Latest News
February 14th 2017
HHS Guidance Requires Specialty Pharmacies to Scrutinize Patient Cost-Sharing and Incentive Programs
Specialty pharmacies will need to carefully consider the effect of the final rule regarding Anti-Kickback Statute safe harbors and Civil Monetary Penalty Law exceptions on their existing patient benefit programs.
Advertisement
CME Content
Advertisement
Marc O'Connor, CEO and chief strategy officer of Curant Health, discusses how projected drug spending growth will alter the specialty pharmacy landscape in the future.
Top news of the week on Specialty Pharmacy Times.
Mark Tesell, PharmD, BCPS, discusses trends that could impact specialty pharmacy well into the future.
Pharmacists most frequently become the formal and informal leaders for the specialty pharmacies they work in.
Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses effective measures for maintaining adherence to specialty drug regimens.
Rebekah L. Hanson, PharmD, BCPS, BCACP, clinical pharmacist and assistant professor at UIC College of Pharmacy, discusses the challenges patients face when starting a specialty medication regimen.
Active Patient Support and Personalization Key to Improving Adherence Rates and Reducing Viral Loads
Advances in the support of patients with HIV include remarkable new pharmaceutical therapies, collaborative care, outstanding patient support, and medication management.
Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses government action that could influence specialty pharmacy.
Last week, the House of Representatives passed an updated version of the 21st Century Cures Act, which could have a significant impact on specialty pharmacy.
Proper succession planning for your pharmacist-in-charge is a must for continuity of business.
Top news of the week on Specialty Pharmacy Times.
Wayne Grau, vice president of Legislative Affairs at Managed Health Care Associates, discusses the implications of the Medicare Home Infusion Site of Care Act for specialty pharmacy stakeholders.
Reduced reimbursements, Medicare Part D, and the Affordable Care Act have stimulated pharmacies to offer a broader palette of services.
Stacey Ness, PharmD, RPh, CSP, MSCS, AAHIVP, senior director of Specialty Clinical Services at Managed Health Care Associates, discusses how specialty stakeholders will need to alter current patient management programs as new drugs transform the treatment of diseases into more manageable conditions.
John Campo, vice president of Specialty Pharmacy Trade Relations and Contracting at Managed Health Care Associates, discusses optimal use of data analytics in specialty pharmacy.
Top articles of the week on Specialty Pharmacy Times.
Paul LeVine, vice president of Analytic Services at TrialCard, discusses how specialty pharmacies can best support patients on a specialty drug therapy.
Premiums in employer plans are growing more slowly on average, as are individual income levels.
Mark A. Vineis, vice president of Specialty Pharmacy at Cardinal Health, discusses how the growing population of older Americans could impact the specialty pharmacy landscape.
Top articles of the week on Specialty Pharmacy Times.
Kevin James, RPh, MBA, vice president of Payer Strategy at US Bioservices, discusses lessons the specialty industry learned from the impact of high cost drug launches for hepatitis C and high cholesterol.
Developing industry connections is crucial for aspiring pharmacists.
Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses how to address the challenge of access to high cost specialty medications.
An award of $347 million has been given to 16 organizations involved with the Hospital Improvement and Innovation Network.
Advertisement
Advertisement
Trending on Pharmacy Times - Pharmacy Practice News and Expert Insights
1
Understanding RSV in Older Adults: Risks, Symptoms, and Barriers to Vaccination
2
Patients Critically Ill With COVID-19 Have Heightened Risk of Pulmonary Fibrosis
3
Study Finds CGMs Could Overestimate Food’s Impact on Blood Sugar Among Nondiabetic Individuals
4
Evinacumab-dgnb Approved For Children Aged 1-5 With Rare Form of High Cholesterol
5
